Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in


Journal

Recent patents on biotechnology
ISSN: 2212-4012
Titre abrégé: Recent Pat Biotechnol
Pays: United Arab Emirates
ID NLM: 101309942

Informations de publication

Date de publication:
03 08 2022
Historique:
received: 11 11 2021
revised: 30 01 2022
accepted: 03 03 2022
pubmed: 15 4 2022
medline: 19 8 2022
entrez: 14 4 2022
Statut: ppublish

Résumé

Insulin-like growth factor-1 (IGF-1) is structurally similar to insulin and acts as an endocrine hormone secreted by the liver. Production of recombinant human IGF-1 (rhIGF-1) in hIGF-1 gene cloned into pBSK (+) simple vector was transformed into TOP 10 chemically competent cells of rhIGF-1 was purified from the HiTrap-ANX column at a concentration of 300 μg/ml. Western blot showed a single 7.6 kDa band obtained in the induced Rosetta (DE3) pLYsS. ELISA confirmed the molecular identity of the rhIGF-1 epitope, the concentration of purified rhIGF-1 obtained from the ELISA standard curve using rhIGF-1 reference protein as a standard was 300 μg/ml, and activity on WI-38 cells was 2604.17I U/mg. Biologically active native rhIGF-1 protein was successfully expressed. Patents related to the preparation of IGF-1 were mentioned along the text.

Sections du résumé

BACKGROUND
Insulin-like growth factor-1 (IGF-1) is structurally similar to insulin and acts as an endocrine hormone secreted by the liver.
OBJECTIVE
Production of recombinant human IGF-1 (rhIGF-1) in
METHODS
hIGF-1 gene cloned into pBSK (+) simple vector was transformed into TOP 10 chemically competent cells of
RESULTS
rhIGF-1 was purified from the HiTrap-ANX column at a concentration of 300 μg/ml. Western blot showed a single 7.6 kDa band obtained in the induced Rosetta (DE3) pLYsS. ELISA confirmed the molecular identity of the rhIGF-1 epitope, the concentration of purified rhIGF-1 obtained from the ELISA standard curve using rhIGF-1 reference protein as a standard was 300 μg/ml, and activity on WI-38 cells was 2604.17I U/mg.
CONCLUSION
Biologically active native rhIGF-1 protein was successfully expressed. Patents related to the preparation of IGF-1 were mentioned along the text.

Identifiants

pubmed: 35418294
pii: BIOT-EPUB-122487
doi: 10.2174/1872208316666220412105822
doi:

Substances chimiques

IGF1 protein, human 0
Insulin-Like Growth Factor I 67763-96-6
Recombinant Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

266-280

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Omnia A Mohamed (OA)

Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt.

Safia Samir (S)

Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt.

Hanan Omar (H)

Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt.

Ekrami A Hassan (EA)

Biochemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt.

Eman Abdelazeem (E)

Biochemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH